TCGA-ZF-A9RL-01A-11R-A38B-07
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 88.79763469
- os_event
- false
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- BILE_ACID_METABOLISM+0.210
- ANDROGEN_RESPONSE+0.170
- PEROXISOME+0.170
- G2M_CHECKPOINT+0.140
- SPERMATOGENESIS+0.120
- PROTEIN_SECRETION+0.110
- FATTY_ACID_METABOLISM+0.080
- TGF_BETA_SIGNALING+0.080
- MTORC1_SIGNALING+0.050
- XENOBIOTIC_METABOLISM+0.010
Top 10 suppressed
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.630
- ALLOGRAFT_REJECTION-0.550
- INFLAMMATORY_RESPONSE-0.530
- INTERFERON_ALPHA_RESPONSE-0.520
- ANGIOGENESIS-0.510
- INTERFERON_GAMMA_RESPONSE-0.500
- TNFA_SIGNALING_VIA_NFKB-0.500
- IL6_JAK_STAT3_SIGNALING-0.470
- APICAL_JUNCTION-0.440
- COMPLEMENT-0.390
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | TCGA-DK-AA76-01A-11R-A39I-07 | — | — | 0.930 |
| 2 | TCGA-GV-A3JW-01A-11R-A20F-07 | — | — | 0.921 |
| 3 | DRR168589 | — | — | 0.890 |
| 4 | SRR8943016 | — | — | 0.889 |
| 5 | TCGA-CN-6988-01A-11R-1915-07 | — | — | 0.888 |
| 6 | TCGA-GU-A42P-01A-11R-A23W-07 | — | — | 0.885 |
| 7 | TCGA-G2-A3VY-01A-11R-A22U-07 | — | — | 0.880 |
| 8 | TCGA-A7-A0DC-01A-11R-A00Z-07 | — | D | 0.879 |
| 9 | TCGA-FJ-A3ZE-01A-11R-A23N-07 | — | — | 0.874 |
| 10 | SRR8943037 | — | — | 0.863 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 10 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| BILE_ACID_METABOLISM | 0.210 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.170 | Inavolisib | — uncovered |
| PEROXISOME | 0.170 | Idelalisib | — uncovered |
| G2M_CHECKPOINT | 0.140 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.120 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.110 | Remibrutinib | — uncovered |
| FATTY_ACID_METABOLISM | 0.080 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.080 | Inavolisib | — uncovered |
| MTORC1_SIGNALING | 0.050 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.010 | Inavolisib | — uncovered |